225 related articles for article (PubMed ID: 8244103)
21. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
22. Adhesion molecules in inflammatory bowel disease.
Jones SC; Banks RE; Haidar A; Gearing AJ; Hemingway IK; Ibbotson SH; Dixon MF; Axon AT
Gut; 1995 May; 36(5):724-30. PubMed ID: 7541009
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease.
Bernstein CN; Sargent M; Rawsthorne P; Rector E
Dig Dis Sci; 1997 Nov; 42(11):2338-49. PubMed ID: 9398815
[TBL] [Abstract][Full Text] [Related]
24. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
25. Sequelae of colectomy and ileostomy: comparison between Crohn's colitis and ulcerative colitis.
Steinberg DM; Allan RN; Brooke BN; Cooke WT; Williams JA
Gastroenterology; 1975 Jan; 68(1):33-9. PubMed ID: 1116664
[TBL] [Abstract][Full Text] [Related]
26. Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
Ananthakrishnan AN; Khalili H; Song M; Higuchi LM; Lochhead P; Richter JM; Chan AT
Inflamm Bowel Dis; 2017 Nov; 23(11):1898-1904. PubMed ID: 28991856
[TBL] [Abstract][Full Text] [Related]
27. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease.
Kuroki F; Iida M; Matsumoto T; Aoyagi K; Kanamoto K; Fujishima M
Dig Dis Sci; 1997 Jun; 42(6):1137-41. PubMed ID: 9201073
[TBL] [Abstract][Full Text] [Related]
28. Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection.
Petersen AM; Schou C; Mirsepasi H; Engberg J; Friis-Møller A; Nordgaard-Lassen I; Wildt S; Krogfelt KA
Scand J Gastroenterol; 2012 Feb; 47(2):155-61. PubMed ID: 22150030
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte chemotaxis in ulcerative colitis.
Belsheim J; Gnarpe H; Swahn A
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):75-9. PubMed ID: 6711311
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
31. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
32. Rescue Diverting Loop Ileostomy: An Alternative to Emergent Colectomy in the Setting of Severe Acute Refractory IBD-Colitis.
Russell TA; Dawes AJ; Graham DS; Angarita SAK; Ha C; Sack J
Dis Colon Rectum; 2018 Feb; 61(2):214-220. PubMed ID: 29337777
[TBL] [Abstract][Full Text] [Related]
33. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease.
Weber P; Husemann S; Vielhaber H; Zimmer KP; Nowak-Göttl U
J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):418-22. PubMed ID: 10204507
[TBL] [Abstract][Full Text] [Related]
34. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
35. Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study.
Nordenvall C; Ekbom A; Bottai M; Smedby KE; Nilsson PJ
Aliment Pharmacol Ther; 2014 Aug; 40(3):280-7. PubMed ID: 24943679
[TBL] [Abstract][Full Text] [Related]
36. Circulating von Willebrand factor in inflammatory bowel disease.
Stevens TR; James JP; Simmonds NJ; McCarthy DA; Laurenson IF; Maddison PJ; Rampton DS
Gut; 1992 Apr; 33(4):502-6. PubMed ID: 1582595
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
39. Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial.
Strik AS; van de Vrie W; Bloemsaat-Minekus JPJ; Nurmohamed M; Bossuyt PJJ; Bodelier A; Rispens T; van Megen YJB; D'Haens GR;
Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):404-412. PubMed ID: 29606564
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
